1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63B080C48198A6F1200258975004B5C45
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/3B080C48198A6F1200258975004B5C45?OpenDocument
18
19OpenDocument
2035.175.191.46
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Patient Focused Services Patient-Centric Initiatives

Document Excerpt: Patient-Driven Growth: Maximizing Patient Co-Creation

DB Image

ID: MD-854


Features:

16 Info Graphics

12 Data Graphics

230+ Metrics

17 Narratives


Pages/Slides: 4


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5754 “Patient-Driven Growth: Maximizing Patient Co-Creation”.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
Alkermes; Astellas; AstraZeneca; Bayer; BELLUS Health; Biogen; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; CSL Behring; Debiopharm; Eli Lilly and Company; GlaxoSmithKline ; Janssen; Jazz Pharmaceuticals; Kala Pharmaceuticals; Inc.; Mitsubishi Tanabe Pharma Corporation; Novartis; Novo Nordisk; Organon; OTSUKA; Pfizer; Sanofi; Sunovion; Takeda Pharmaceuticals; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.